Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 18 studies | 29% ± 12% | |
monocyte | 6 studies | 21% ± 5% | |
classical monocyte | 5 studies | 24% ± 6% | |
natural killer cell | 5 studies | 17% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 18% ± 2% | |
hepatocyte | 4 studies | 41% ± 18% | |
enteroendocrine cell | 4 studies | 53% ± 17% | |
pancreatic A cell | 3 studies | 54% ± 28% | |
epithelial cell | 3 studies | 23% ± 9% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
pancreas | 3 studies | 39% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1972.56 | 578 / 578 | 100% | 24.86 | 1154 / 1155 |
stomach | 98% | 548.91 | 352 / 359 | 100% | 22.05 | 286 / 286 |
breast | 99% | 770.22 | 455 / 459 | 99% | 22.06 | 1103 / 1118 |
liver | 100% | 5162.17 | 226 / 226 | 98% | 33.17 | 397 / 406 |
pancreas | 99% | 464.08 | 326 / 328 | 98% | 27.15 | 175 / 178 |
prostate | 100% | 735.60 | 244 / 245 | 97% | 13.20 | 487 / 502 |
bladder | 95% | 680.19 | 20 / 21 | 99% | 23.97 | 499 / 504 |
intestine | 92% | 796.74 | 889 / 966 | 100% | 27.83 | 525 / 527 |
kidney | 100% | 1351.54 | 89 / 89 | 90% | 10.46 | 807 / 901 |
thymus | 99% | 513.13 | 645 / 653 | 89% | 9.07 | 537 / 605 |
uterus | 92% | 335.21 | 156 / 170 | 95% | 27.20 | 438 / 459 |
adrenal gland | 96% | 653.44 | 247 / 258 | 89% | 152.71 | 205 / 230 |
esophagus | 84% | 597.92 | 1211 / 1445 | 98% | 21.45 | 180 / 183 |
skin | 93% | 644.13 | 1674 / 1809 | 73% | 11.98 | 345 / 472 |
ovary | 67% | 247.91 | 121 / 180 | 83% | 8.32 | 358 / 430 |
brain | 80% | 374.80 | 2102 / 2642 | 30% | 2.50 | 209 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.89 | 29 / 29 |
spleen | 100% | 1347.80 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.34 | 1 / 1 |
adipose | 100% | 831.49 | 1198 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1551.59 | 914 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 36.23 | 44 / 45 |
blood vessel | 88% | 431.88 | 1179 / 1335 | 0% | 0 | 0 / 0 |
heart | 83% | 315.69 | 714 / 861 | 0% | 0 | 0 / 0 |
muscle | 30% | 82.22 | 241 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 1.51 | 16 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006729 | Biological process | tetrahydrobiopterin biosynthetic process |
GO_0008217 | Biological process | regulation of blood pressure |
GO_2000773 | Biological process | negative regulation of cellular senescence |
GO_0014916 | Biological process | regulation of lung blood pressure |
GO_0034612 | Biological process | response to tumor necrosis factor |
GO_0050884 | Biological process | neuromuscular process controlling posture |
GO_0034341 | Biological process | response to type II interferon |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_2000121 | Biological process | regulation of removal of superoxide radicals |
GO_0042416 | Biological process | dopamine biosynthetic process |
GO_0042559 | Biological process | pteridine-containing compound biosynthetic process |
GO_0051066 | Biological process | dihydrobiopterin metabolic process |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0046654 | Biological process | tetrahydrofolate biosynthetic process |
GO_0048265 | Biological process | response to pain |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0051000 | Biological process | positive regulation of nitric-oxide synthase activity |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0042311 | Biological process | vasodilation |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0044306 | Cellular component | neuron projection terminus |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003934 | Molecular function | GTP cyclohydrolase I activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0030742 | Molecular function | GTP-dependent protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0051019 | Molecular function | mitogen-activated protein kinase binding |
GO_0005525 | Molecular function | GTP binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GCH1 |
Protein name | GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I) |
Synonyms | DYT5 GCH |
Description | FUNCTION: Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown. . |
Accessions | ENST00000491895.7 [P30793-1] ENST00000543643.6 [P30793-4] ENST00000395514.5 [P30793-1] P30793 ENST00000536224.2 [P30793-2] |